Protective Stepping in People With MS
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT03551665
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Protective step training — BEHAVIORALParticipants will undergo 2 weeks of training, in which they will be exposed to repeated slips on a treadmill. This approach is aimed at improving protective steps.
Study Details
Falls are common in Veterans with multiple sclerosis (MS), and current rehabilitation approaches to reduce falls are inadequate. Protective step training (in which a person is exposed to repeated "slips") is a promising tool to reduce falls in older adults. However, whether this approach is effective in people with MS is unknown. Investigating the effect of promising therapies, such as protective step training, will enhance our ability to treat Veterans with MS who are at risk for falls. Therefore, we will assess whether people with MS improve postural control and reduce falls through protective step training. we will also determine whether cognitive ability or brain structure can predict who will improve most. These data will inform clinical treatment strategies in people with MS at risk for falls.
Key Dates
- Start date
- Feb 22, 2019
- Status verified
- Jun 2025
- Primary completion
- Jul 24, 2024
- Completion
- Aug 1, 2024
Study Design
- Enrollment
- 57 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Step trainingThis group will undergo a baseline control period, as well as an intervention period. As such, they will serve as their own control subjects.
Primary Outcome Measure
Training-related Change in Margin of Stability [ Time Frame: Baseline and Post-test (immediately after the intervention) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix VA Health Care System, Phoenix, AZ | Phoenix | Arizona | 85012 | - |
Find similar trials in Phoenix, AZ
Related Studies
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting · TG Therapeutics, Inc. · Birmingham, Alabama
- An Open-label Study of AZD0120 in Adults With Multiple SclerosisPHASE1 · Recruiting · AstraZeneca · Tucson, Arizona
- Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPHASE3 · Recruiting · Sanofi · Cullman, Alabama
- A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 TherapyPHASE4 · Not Yet Recruiting · Genentech, Inc. · Birmingham, Alabama